Ocular Manifestations of Candidemia | Zendy

Astrid M. L. Oude Lashof | Zendy; Aniki Rothová | Zendy; Jack D. Sobel | Zendy; Markus Ruhnke | Zendy; Peter G. Pappas | Zendy; Claudio Viscoli | Zendy; Haran T. Schlamm | Zendy; I. T. Oborska | Zendy; John Rex | Zendy; Bart Jan Kullberg | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Ocular Manifestations of Candidemia

Author(s) -

Astrid M. L. Oude Lashof,

Aniki Rothová,

Jack D. Sobel,

Markus Ruhnke,

Peter G. Pappas,

Claudio Viscoli,

Haran T. Schlamm,

I. T. Oborska,

John Rex,

Bart Jan Kullberg

Publication year - 2011

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cir355

Subject(s) - medicine , fluconazole , voriconazole , amphotericin b , chorioretinitis , endophthalmitis , mycosis , surgery , incidence (geometry) , randomized controlled trial , ophthalmology , dermatology , antifungal , physics , optics

Ocular candidiasis is a major complication of candidemia. The incidence, risk factors, and outcome of eye involvement during candidemia are largely unknown. We prospectively studied the ocular manifestations of candidemia in a large, worldwide, randomized multicenter trial that compared voriconazole with amphotericin B followed by fluconazole for the treatment of candidemia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research